Original Research
Published on 11 Jun 2024
Development and validation of UPLC-MS/MS method for icariin and its metabolites in mouse urine
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389754
- 629 views
Type at least 3 characters
725 articles
Articles
Original Research
Published on 24 May 2024
Amino acid metabolomics and machine learning for assessment of post-hepatectomy liver regeneration
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1345099
- 1,261 views
Original Research
Published on 24 May 2024
The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1392849
- 1,037 views
Original Research
Published on 23 May 2024
Pharmacokinetic assessment of tacrolimus in combination with deoxyschizandrin in rats
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1344369
- 948 views
Original Research
Published on 22 May 2024
Simultaneous determination of multiple components in rat plasma by UPLC-MS/MS for pharmacokinetic studies after oral administration of Pogostemon cablin extract
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1293464
- 840 views
Clinical Trial
Published on 17 May 2024
A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm® in healthy Chinese subjects
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1328142
- 1,078 views
Original Research
Published on 16 May 2024
Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387057
- 844 views
Original Research
Published on 10 May 2024
The cardiovascular toxicity of polystyrene microplastics in rats: based on untargeted metabolomics analysis
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1336369
- 1,862 views
- 3 citations
Original Research
Published on 09 May 2024
Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in chinese renal transplant recipients
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389271
- 1,319 views
Review
Published on 07 May 2024
Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393409
- 1,989 views
- 3 citations
Original Research
Published on 02 May 2024
Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1378872
- 1,111 views
Original Research
Published on 02 May 2024
Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1342515
- 1,422 views
Original Research
Published on 29 Apr 2024
In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1391689
- 6,902 views
- 4 citations
Original Research
Published on 29 Apr 2024
The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1327008
- 1,218 views
Original Research
Published on 29 Apr 2024
The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373048
- 836 views
Original Research
Published on 19 Apr 2024
Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1349244
- 1,094 views